Stephen Gould - Director, Principal Scientist (technology), Translational Oncology/In vivo pharmacology and antibody conjugates

Stephen Gould

Director, Principal Scientist (technology), Translational Oncology/In vivo pharmacology and antibody conjugates

"Our goal of identifying and developing transformative medicines to treat diseases with unmet need can only be achieved through rigorous science and deep collaboration among truly gifted people."
11
Years at Genentech
36
Publications
6
Awards & Honors

I joined Genentech in 2006 after seven years in the Boston biotech sector, four of which were spent in a productive collaboration with scientists here at Genentech. The decision to become an East Coast transplant was driven by my passion to take small molecule drugs from concept to patients, and to do so in an environment driven by science and the desire to have a dramatic impact on patient outcome.

Featured Publication

Translational value of mouse models in oncology drug development.

Nat Med. 2015; 21(5):431-9.

Gould SE, Junttila MR, de Sauvage FJ.